Search results
Antibody-displaying extracellular vesicles for targeted cancer therapy - Nature Biomedical...
Nature· 5 days agoExtracellular vesicles decorated with an antibody-binding moiety specific for the fragment crystallizable domain can be used as a modular delivery system for targeted cancer therapy.
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions of Undisclosed Antibodies...
JD Supra· 3 days agoAmgen...
Experimental HIV Vaccine Successfully Triggers Potent Antibodies in Humans
ScienceAlert via Yahoo News· 4 days agoThe phase I clinical trial, which began in 2019, enrolled 24 healthy participants, 4 of whom received a placebo. But the trial was halted after one person had a severe allergic ...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 5 hours agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
What Is the Rarest Blood Type?
Verywell Health via Yahoo News· 2 days agoHowever, there are several different subtypes of A, B, and Rh antigens. Sometimes, genetic testing can provide even more precise test results than...
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 3 days agoThose who are more vulnerable to getting sick during a spring or summer surge may benefit from the...
Why is immunotheraphy not being used as a tool in the war against Alzheimer's Disease?
Lohud | The Journal News via Yahoo News· 11 hours agoThe drug slowed progression about 4 ½ months during the 18-month clinical trial compared to placebo....
Newfound autoimmune syndrome tied to COVID-19 can trigger deadly lung scarring
Live Science via Yahoo News· 6 days agoAn illustration of Y shaped antibodies in front of a coronavirus particle, blurred in the...
Outbreak of Human Trichinellosis ...
Centers for Disease Control and Prevention· 2 days agoThe index patient’s diagnosis was confirmed by a positive Trichinella immunoglobulin (Ig) G antibody test result. Six days before symptom onset in the...
ASCO: With hopes high, Regeneron misses mark with just 1 complete response in solid tumor trial so...
FierceBiotech· 23 hours agoRegeneron’s costimulatory bispecific antibody REGN7075 is being tested in patients with advanced...
